Gambaran Klinis dan Patologi Melanoma Maligna Kutaneus
DOI:
https://doi.org/10.55175/cdk.v47i9.563Kata Kunci:
Klinis, melanoma kutaneus, patologisAbstrak
Melanoma maligna (MM) merupakan keganasan sel-sel melanosit terutama di kulit. Paling sering didiagnosis pada pada wanita <40 tahun, dan pada pria >40 tahun. Predileksi MM tersering pada kulit punggung (pria) dan pada ekstremitas bawah (wanita). Secara klinis dan patologis, melanoma maligna diklasifikasikan sebagai superficial spreading melanoma, nodular melanoma, lentigo maligna melanoma, acral lentiginous melanoma, dan varian lain yang jarang.
Malignant melanoma (MM) is melanocyte cells malignancy located mainly in the skin; most often diagnosed in women <40 years, and in men >40 years. MM predilection is in the back (men) and in lower extremities (women). Clinically and pathologically, malignant melanoma is classified as superficial spreading melanoma, nodular melanoma, lentigo maligna melanoma, acral lentiginous melanoma, and other rare variants
Unduhan
Referensi
Arrangoiz R, Dorantes J, Cordera F, Juarez MM, Paquentin EM, León EL. Melanoma review: Epidemiology, risk factors, diagnosis and staging. J Cancer Treatment and Research 2016;4(1):1-15.
Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, et al. Melanoma clinical practice guidelines in oncology. JNCCN 2012;10(3):366-400.
Eggermont AMM, Spatz A, Robert C. Cutaneous melanoma. Lancet 2014;383:816–27.
Azimi F, Scolyer RA, Rumcheva P, Moncrief M, Murali R, Mc Carthy SW, et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol. 2012;30(21): 2678-83.
McCourt C, Dolan O, Gormley G. Malignant melanoma: A pictorial review. Ulster Med J. 2014;83(2):103-10.
Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JWW. Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008;44:1345–89.
Stang A, Valiukeviciene S, Aleknaviciene B, Kurtinaitis J. Time trends of incidence, mortality, and relative survival of invasive skin melanoma in Lithuania. Eur J Cancer 2006;42:660–7.
Levine SM, Shapiro RL. Surgical treatment of malignant melanoma-practical guidelines. Dermatol Clin. 2012;30:487–501.
Paek S, Sober AJ, Tsao H, Mihm MC, Johnson TM. Cutaneous melanoma. In: Wolff K, GoldSmith LS, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, eds. Fitzpatrick’s dermatology in general medicine. 7th ed. New York: McGraw Hill Co; 2008 .p. 1134-57.
Bandarchi B, Ma L, Navab R, Seth A, Rasty G. From melanocyte to metastatic malignant melanoma. Dermatol Res Pract. 2010;2010:583748.
Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, Spatz A, et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guidelineUpdate 2012. Eur J Cancer 2012;48:2375–9
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2020 https://creativecommons.org/licenses/by-nc/4.0/
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
